BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31683101)

  • 1. Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.
    Hwang B; Shin SS; Song JH; Choi YH; Kim WJ; Moon SK
    J Nutr Biochem; 2019 Dec; 74():108230. PubMed ID: 31683101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo.
    Shin SS; Park YJ; Hwang B; Park SL; Han SW; Park SS; Choi YH; Kim WJ; Moon SK
    Phytomedicine; 2019 Nov; 64():153069. PubMed ID: 31421400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo anti-tumor efficacy of krill oil against bladder cancer: Involvement of tumor-associated angiogenic vasculature.
    Kim H; Roh Y; Yong Park S; Lee C; Lim S; Cho S; Lee HY; Auck Hong S; Jin Lee T; Chul Myung S; Yun SJ; Hyun Choi Y; Kim WJ; Moon SK
    Food Res Int; 2022 Jun; 156():111144. PubMed ID: 35651016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo.
    Kim EC; Kim SH; Piao SJ; Kim TJ; Bae K; Kim HS; Hong SS; Lee BI; Nam M
    J Korean Med Sci; 2015 Jul; 30(7):979-87. PubMed ID: 26130964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
    Cho HD; Lee KW; Won YS; Kim JH; Seo KI
    J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hwang B; Gho Y; Kim H; Lee S; Hong SA; Lee TJ; Myung SC; Yun SJ; Choi YH; Kim WJ; Moon SK
    Integr Cancer Ther; 2022; 21():15347354221114337. PubMed ID: 35912937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Antitumor Efficacy of
    Song JH; Won SY; Hwang B; Jung S; Choi C; Park SS; Choi YH; Kim WJ; Moon SK
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
    Ceci C; Tentori L; Atzori MG; Lacal PM; Bonanno E; Scimeca M; Cicconi R; Mattei M; de Martino MG; Vespasiani G; Miano R; Graziani G
    Nutrients; 2016 Nov; 8(11):. PubMed ID: 27879653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Hai-Rong C; Xiang H; Xiao-Rong Z
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.
    Qian X; Zhu L; Hu J; Li M; Xie L; Wang L; Yu L; Liu B
    J Ethnopharmacol; 2012 Aug; 143(1):256-61. PubMed ID: 22750432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression.
    Shin SS; Noh DH; Hwang B; Lee JW; Park SL; Park SS; Moon B; Kim WJ; Moon SK
    Int J Nanomedicine; 2018; 13():3295-3310. PubMed ID: 29910616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.